Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference

Rhea-AI Summary

Vor Bio (Nasdaq: VOR) will present and hold 1x1 investor meetings at the 46th Annual TD Cowen Health Care Conference in Boston.

The company presentation is scheduled for Monday, March 2, 2026, 9:50–10:20 AM ET. A live webcast and archived replay will be available for 90 days on the company website.

News Market Reaction – VOR

+13.80%

46 alerts

+13.80% Session close to close

+12.8% Peak in 1 hr 51 min

$663.49M Market Cap

0.9x Rel. Volume

In the Feb 23 session, VOR gained 13.80%, reflecting a significant positive market reaction. Argus tracked a peak move of +12.8% during that session. Our momentum scanner triggered 46 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +13.8% in the session following this news. A strong positive reaction aligns with p...

Analysis

The stock surged +13.8% in the session following this news. A strong positive reaction aligns with prior experience where conference participation, such as the J.P. Morgan event on Jan 13, 2026, coincided with a 10.3% gain. However, the stock still trades well below its 52-week high of $65.80 and under the 200-day MA of $22.34. Investors have also faced ongoing equity issuance and a resale shelf, factors that could temper or reverse momentum if selling pressure increases.

Key Figures

Conference edition: 46th Annual TD Cowen Health Care Conference Presentation date: March 2, 2026 Presentation time: 9:50am–10:20am ET +1 more

4 metrics

Conference edition 46th Annual TD Cowen Health Care Conference Event Vor Bio plans to attend

Presentation date March 2, 2026 Scheduled TD Cowen conference presentation

Presentation time 9:50am–10:20am ET Vor Bio conference presentation window

Webcast availability 90 days Duration replay will remain available on company website

Historical Context

5 past events · Latest: Jan 06 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jan 06	Conference participation	Neutral	+10.3%	Announced presentation and 1x1 meetings at J.P. Morgan healthcare conference.
Dec 23	Board appointments	Positive	-1.3%	Added two investor-affiliated directors following a $150M PIPE financing.
Dec 15	Private placement	Neutral	+8.0%	Announced $150M private placement to fund telitacicept Phase 3 programs.
Nov 13	Earnings and update	Negative	-3.1%	Reported Q3 2025 results with strong efficacy but very large net loss.
Nov 10	Equity offering	Negative	+0.5%	Priced $100M common stock offering under existing shelf registration.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent financings and conference appearances often saw modestly positive or mixed price reactions, while a mixed earnings update aligned with a mild decline.

Recent Company History

Over the last few months, Vor Bio announced multiple capital raises and investor outreach events. A $100M public offering on Nov 10, 2025 and a $150M private placement on Dec 15, 2025 strengthened the balance sheet. Q3 2025 results on Nov 13, 2025 highlighted broad Phase 3 efficacy for telitacicept but also a large net loss and high liabilities. Conference participation, such as the 44th Annual J.P. Morgan Healthcare Conference in January 2026, previously coincided with a strong positive move, providing context for today’s TD Cowen conference appearance.

Key Terms

1x1 investor meetings

1 terms

1x1 investor meetings financial

"it will be presenting and hosting 1x1 investor meetings at the 46th Annual"

1x1 investor meetings are private discussions between a company's management and individual investors, typically lasting around an hour. These meetings allow investors to ask questions, gain a deeper understanding of the company's strategy and performance, and build a direct relationship with leadership. They matter to investors because they provide valuable insights that can influence investment decisions and foster greater confidence in the company's prospects.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting and hosting 1x1 investor meetings at the 46th Annual TD Cowen Health Care Conference in Boston, MA.

Presentation: Monday, March 2, 2026 at 9:50am – 10:20 am ET
Location: Regis

A live webcast and archived replay of the presentation will be remain available for a period of 90 days on the Company’s website at: https://ir.vorbio.com/events-presentations/

About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.

Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com

Sarah Spencer
investors@vorbio.com

FAQ

When will Vor Bio (VOR) present at the TD Cowen conference in 2026?

Vor Bio will present on Monday, March 2, 2026, from 9:50–10:20 AM ET. According to Vor Bio, the presentation is part of the 46th Annual TD Cowen Health Care Conference in Boston and will include a company overview and investor Q&A.

Will Vor Bio (VOR) host one-on-one investor meetings at the March 2026 TD Cowen conference?

Yes, Vor Bio will host 1x1 investor meetings at the conference. According to Vor Bio, management will meet with investors in Boston around the presentation date to discuss clinical progress and corporate strategy.

How can investors watch Vor Bio's (VOR) TD Cowen presentation if they cannot attend in person?

Investors can view a live webcast and archived replay on the company website. According to Vor Bio, the webcast will be posted and remain available for 90 days after the presentation for on-demand viewing.

Where will Vor Bio's (VOR) TD Cowen presentation be held and who is the audience?

The presentation takes place in Boston, MA at the TD Cowen conference and targets institutional investors and analysts. According to Vor Bio, the session will include management remarks and investor-focused discussion of clinical programs.

What topics is Vor Bio (VOR) likely to cover at the March 2, 2026 presentation?

The presentation will focus on Vor Bio's clinical-stage programs and corporate strategy for autoimmune diseases. According to Vor Bio, management will review recent clinical updates and engage with investors on development plans and timelines.